997 related articles for article (PubMed ID: 28883691)
21. HCC and Tumor Biomarkers: Does One Size Fits All?
Ozgor D; Otan E
J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
[TBL] [Abstract][Full Text] [Related]
22. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
[TBL] [Abstract][Full Text] [Related]
23. [Possibilities of liquid biopsy in gastric cancer].
Zakharenko AA; Zaitsev DA; Belyaev MA; Trushin AA; Ten OA; Natkha AS
Vopr Onkol; 2016; 62(4):379-85. PubMed ID: 30474943
[TBL] [Abstract][Full Text] [Related]
24. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
26. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
[TBL] [Abstract][Full Text] [Related]
27. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.
Dhayat SA; Yang Z
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1625-1645. PubMed ID: 32338295
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W
Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136
[TBL] [Abstract][Full Text] [Related]
29. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy in liver cancer.
Labgaa I; Villanueva A
Discov Med; 2015 Apr; 19(105):263-73. PubMed ID: 25977189
[TBL] [Abstract][Full Text] [Related]
31. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy for liver diseases.
Mann J; Reeves HL; Feldstein AE
Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
[TBL] [Abstract][Full Text] [Related]
34. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
35. Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma.
Pinato DJ
Oncogene; 2018 Aug; 37(34):4635-4638. PubMed ID: 29755128
[No Abstract] [Full Text] [Related]
36. Advances in Cancer Therapy: Liquid Biopsy.
Marmé D
Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
[No Abstract] [Full Text] [Related]
37. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
Park S; Lee EJ; Rim CH; Seong J
Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
[TBL] [Abstract][Full Text] [Related]
38. Role of liver biopsy in hepatocellular carcinoma.
Di Tommaso L; Spadaccini M; Donadon M; Personeni N; Elamin A; Aghemo A; Lleo A
World J Gastroenterol; 2019 Oct; 25(40):6041-6052. PubMed ID: 31686761
[TBL] [Abstract][Full Text] [Related]
39. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
Mezzalira S; De Mattia E; Guardascione M; Dalle Fratte C; Cecchin E; Toffoli G
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694149
[TBL] [Abstract][Full Text] [Related]
40. Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma.
Zhou J; Shi YH; Fan J
Semin Oncol; 2012 Aug; 39(4):440-8. PubMed ID: 22846861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]